Aerovate Therapeutics is based out of Waltham. Aerovate Therapeutics, Inc. is a clinical stage biopharmaceutical company whose mission is to advance novel therapeutics and to help people with rare cardiopulmonary diseases gain control over their health, and their lives. The firm last filed a Form D notice of exempt offering of securities on 2020-08-14. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
AEROVATE THERAPEUTICS, INC.930 WINTER STREET
WALTHAM MA 02451
Business Phone: 617-443-2400
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS